Our manufacturing operations are across two states- Maharashtra and Gujarat. These facilities are built and operated according to the cGMP. Our three facilities are approved by the USFDA (two of them are the bulk drug units at Belapur and Panoli and one is a formulation unit - tablets). These are also approved by reputed international inspection agencies for all our major products.

State-of-the-art equipment and instruments give us the edge to compete globally. We have superior technical & innovation capabilities courtesy our people, who have repeatedly proven their ability to rise to challenges. The infrastructure, with its optimum installed capacities and capital costs, gives us sustainable competitive cost advantage. All our operations are supported by fully integrated Supply Chain practices and SAP System Version 6.0 from June 2008 as a part of up-gradation of our ERP and Management Information system. As an environmentally responsible organisation, our manufacturing operations are equipped with state-of-the-art effluent treatment facilities, including aeration & evaporation systems, zero discharge facilities. Our Bulk Drug operations and infrastructure are engineered to optimise solvent and by-product recoveries. The comprehensive manufacturing services include R&D labs, pilot plants, technical services, quality control, quality assurance and regulatory affairs.

Cough Lozenges are made from well researched formulations under precision manufacturing techniques and stringent quality control in a state-of-the-art manufacturing plant, run by a team of highly qualified professionals.